mladenbalinovac/E+ via Getty Images
Zynex (NASDAQ:ZYXI) rose 2% amid a report that the medical device maker is evaluating its options, including a possible sale.
The company is working with Cantor Fitzgerald to review its options, including a takeover, a merger, a divestiture, a recapitalization, or another transaction, according to a Bloomberg report, which cited people familiar.
There’s no certainty that Zynex (ZYXI) will decide to pursue a deal, according to the report. Zynex has a market cap of $283 million.
